Indivior Pharmaceuticals (INDV) Restructuring Costs (2024 - 2025)

Indivior Pharmaceuticals has reported Restructuring Costs for 2 years, with the latest figure at -$2.0 million in Q4 2025.

• On a quarterly basis, Restructuring Costs changed N/A year-over-year to -$2.0 million in Q4 2025; TTM through Dec 2025 was $1.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$3.0 million, down 175.0% from the prior year.
• Restructuring Costs was -$2.0 million for Q4 2025 at Indivior Pharmaceuticals, down from -$1.0 million in the prior quarter.
• The five-year high for Restructuring Costs was $4.0 million in Q3 2024, with the low at -$2.0 million in Q4 2025.